Zach Weinberg is a prominent American entrepreneur and investor, primarily known for co-founding Flatiron Health, a healthcare technology company focused on accelerating cancer research and improving patient care through real-world evidence. Weinberg's entrepreneurial journey began at the prestigious Wharton School of the University of Pennsylvania, where he co-founded several startups including Invite Media, which was later acquired by Google. Flatiron Health, his most notable venture, was acquired by Roche in a landmark $1.9 billion deal in 2018. Besides his contributions to healthcare technology, Weinberg has actively invested in numerous startups across diverse sectors, further solidifying his influence in the entrepreneurial ecosystem.
In the past few years, Zach Weinberg has remained an influential figure in the technology and healthcare industries through various initiatives and investments.
| Attribute | Information |
|---|---|
| Full Name | Zach Weinberg |
| Born | 1986, United States |
| Nationality | American |
| Occupation | Entrepreneur, Investor |
| Known For | Co-founder of Flatiron Health |
| Net Worth | Not publicly disclosed |
| Education | Wharton School, University of Pennsylvania |
Zach Weinberg grew up in the United States, where from an early age, he developed a keen interest in technology and entrepreneurship. He pursued an education in economics and entrepreneurship at the Wharton School of the University of Pennsylvania, one of the most prestigious business schools globally. During his university years, he met Nat Turner, a future business partner, with whom he shared a penchant for technology-driven solutions to real-world problems. Their academic synergy and shared vision eventually laid the foundation for several successful ventures, including Invite Media and Flatiron Health.
Zach Weinberg's career is marked by a series of entrepreneurial successes:
Currently, Zach Weinberg leads Curie.Bio, focusing on accelerating drug discovery and development by providing startups with essential resources and funding. As an angel investor, he has backed 32 companies, reflecting his objective to support tech-savvy entrepreneurs and innovative ventures. His notable investments align with his vision of marrying technology and healthcare, aiming at breakthroughs that can significantly impact society. Weinberg's ongoing contributions continue to influence strategic directions in both healthcare technology and venture investing.
Zach Weinberg has consistently demonstrated an impressive ability to integrate technology with healthcare analytics, thereby transforming the landscape of data-driven healthcare solutions. His entrepreneurial spirit and investment strategies have not only propelled startups but also paved the way for groundbreaking advancements in cancer research and healthcare delivery. As Weinberg continues to lead and innovate within the biotech sector through Curie.Bio, his impact on healthcare and technology is expected to endure, leaving a lasting legacy for future innovators and entrepreneurs.
